Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

KRMD
KORU Medical Systems, Inc. Common Stock (DE)
stock NASDAQ

At Close
May 16, 2025 3:59:30 PM EDT
2.97USD-2.941%(-0.09)82,930
0.00Bid   0.00Ask   0.00Spread
Pre-market
Dec 31, 1969 7:00:00 PM EST
0.00USD-100.000%(-3.06)0
After-hours
May 16, 2025 4:00:30 PM EDT
2.95USD-0.673%(-0.02)150
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Dec 22, 2021
07:42AM EST  The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda   Benzinga
Dec 21, 2021
04:02PM EST  KORU Medical Reports Receives FDA 510(k) Clearance For Use Of FREEDOM60 With 2 Added Subcutaneous Ig Drugs   Benzinga
04:01PM EST  KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60(r) with Two Additional SCIg Drugs   Business Wire
Dec 20, 2021
11:04AM EST  Repro-Med Systems Granted FDA Approval For FREEDOM Integrated Syringe Infusion System   Benzinga
Dec 1, 2021
04:01PM EST  KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day   Business Wire
Nov 11, 2021
08:03AM EST  The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts   Benzinga
Nov 10, 2021
04:03PM EST  KORU Medical Systems Announces 2021 Third Quarter Financial Results   Business Wire
04:00PM EST  KORU Medical Announces FDA Clearance for Delivery of Hizentra(r) Prefilled Syringes   Business Wire
04:09AM EST  Earnings Scheduled For November 10, 2021   Benzinga
Nov 9, 2021
07:00AM EST  KORU Medical Systems to Participate in Two Upcoming Conferences   Business Wire
Nov 8, 2021
07:23AM EST  KORU Medical Collaborates With Gilero Focus On At-home Infusion products And Portfolio   RTTNews
07:09AM EST  KORU Medical Announces Collaboration With Gilero To Accelerate Innovation   Benzinga
Nov 1, 2021
07:00AM EDT  KORU Medical Expands Senior Team to Accelerate Growth Strategy   Business Wire
Oct 27, 2021
04:01PM EDT  KORU Medical Systems to Report Third Quarter 2021 Financial Results on November 10, 2021   Business Wire
Oct 26, 2021
07:00AM EDT  KORU Medical Appoints Chris Pazdan as Vice President of Quality Assurance and Regulatory Affairs   Business Wire
Aug 11, 2021
05:01PM EDT  Repro-Med Systems: Q2 Earnings Insights   Benzinga
04:11PM EDT  Repro-Med Systems Q2 EPS $(0.02), Inline, Sales $5.50M Beat $5.39M Estimate   Benzinga
04:01PM EDT  KORU Medical Systems Announces 2021 Second Quarter Financial Results   Business Wire
09:06AM EDT  Earnings Scheduled For August 11, 2021   Benzinga
08:14AM EDT  The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering   Benzinga
04:27AM EDT  Earnings Scheduled For August 11, 2021   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
07:00AM EDT  KORU Medical Systems to Participate in Canaccord Genuity's 41st Annual Growth Conference   Business Wire
Aug 8, 2021
10:11AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Jul 28, 2021
07:00AM EDT  KORU Medical Systems to Report Second Quarter 2021 Financial Results on August 11, 2021   Business Wire
May 25, 2021
01:45AM EDT  Investment in Repro Med Systems, Inc. d/b/a KORU Medical Systems of Class Action Lawsuit and Upcoming Deadline - KRMD   PR Newswire
May 19, 2021
11:25PM EDT  SHAREHODLER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
May 18, 2021
04:05AM EDT  Investment in Repro Med Systems, Inc. d/b/a KORU Medical Systems of Class Action Lawsuit and Upcoming Deadline - KRMD   PR Newswire
May 12, 2021
04:59PM EDT  Recap: Repro-Med Systems Q1 Earnings   Benzinga
04:07PM EDT  Repro-Med Systems Q1 EPS $(0.03) Misses $(0.01) Estimate, Sales $5.40M Beat $5.10M Estimate   Benzinga
04:02PM EDT  KORU Medical Systems Announces 2021 First Quarter Financial Results   Business Wire
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
04:22AM EDT  Earnings Scheduled For May 12, 2021   Benzinga
May 11, 2021
06:20PM EDT  Pomerantz Law Firm Announces the Filing of a Class Action Against Repro Med   PR Newswire
Apr 30, 2021
10:10PM EDT  Pomerantz LLP is investigating claims on behalf of investors of Repro-Med Systems, Inc. (d/b/a KORU Medical Systems) (KORU or the Company) (NASDAQ:KRMD). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Apr 28, 2021
04:11PM EDT  KORU Medical Systems to Report First Quarter 2021 Financial Results on May 12, 2021   Business Wire
Apr 24, 2021
08:48PM EDT  Pomerantz LLP is investigating claims on behalf of investors of Repro-Med Systems, Inc. (d/b/a KORU Medical Systems) (KORU or the Company) (NASDAQ:KRMD). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
01:47AM EDT  LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact   PR Newswire
Apr 20, 2021
08:07AM EDT  The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex   Benzinga
Apr 19, 2021
10:18AM EDT  Stocks That Hit 52-Week Lows On Monday   Benzinga
Apr 14, 2021
11:55PM EDT  Pomerantz LLP is investigating claims on behalf of investors of Repro-Med Systems, Inc. (d/b/a KORU Medical Systems) (KORU or the Company) (NASDAQ:KRMD). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
07:51AM EDT  The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead   Benzinga
Mar 31, 2021
05:58PM EDT  Gainey McKenna & Egleston Announces A ClassAction   GlobeNewswire Inc
07:41AM EDT  The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO   Benzinga
Mar 30, 2021
08:06AM EDT  The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings   Benzinga
Mar 23, 2021
05:23PM EDT  Repro-Med Systems: Q4 Earnings Insights   Benzinga
04:04PM EDT  Repro-Med Systems Sees Q1 Sales At Least $5M Vs. $5.35M Est.   Benzinga
04:03PM EDT  Repro-Med Systems Q4 EPS $(0.02) Misses $(0.01) Estimate, Sales $4.10M Miss $4.67M Estimate   Benzinga
04:01PM EDT  KORU Medical Systems Reports Fourth Quarter and Full Year 2020 Financial Results   Business Wire
04:26AM EDT  Earnings Scheduled For March 23, 2021   Benzinga
Mar 19, 2021
08:04AM EDT  KORU Medical Systems Names Linda Tharby President And CEO, Effective April 12   RTTNews
08:04AM EDT  KORU Medical Systems Appoints Linda Tharby As CEO   Benzinga
08:03AM EDT  KORU Medical Names Linda Tharby Pres, CEO   Benzinga
08:00AM EDT  KORU Medical Systems Announces New Chief Executive Officer   Business Wire
Mar 8, 2021
04:01PM EST  KORU Medical Systems to Report Fourth Quarter and Full Year 2020 Financial Results on March 23, 2021   Business Wire
Jan 26, 2021
02:30PM EST  Mid-Afternoon Market Update: Dow Rises 40 Points; Repro Med Systems Shares Plunge   Benzinga
12:45PM EST  Mid-Day Market Update: Crude Oil Down 0.5%; Vir Biotechnology Shares Spike Higher   Benzinga
10:12AM EST  Mid-Morning Market Update: Markets Edge Higher; Verizon Tops Q4 Views   Benzinga
10:03AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2021   Benzinga
08:22AM EST  10 Biggest Price Target Changes For Tuesday   Benzinga
06:11AM EST  Canaccord Genuity Downgrades Repro-Med Systems to Hold, Announces $5 Price Target   Benzinga
06:10AM EST  Piper Sandler Downgrades Repro-Med Systems to Neutral, Lowers Price Target to $4.5   Benzinga
Jan 25, 2021
04:06PM EST  Repro Med Systems Expects FY20 Revenues Of $24.0 Mln   RTTNews
04:04PM EST  KORU Medical Systems CEO And President Don Pettigrew Resigns, Co. Appoints Jim Beck As CEO   Benzinga
04:02PM EST  KORU Medical Systems Sees FY20 Prelim. Sales ~$24M vs. $25.9M Est.   Benzinga
04:01PM EST  KORU Medical Systems Reports Preliminary Full Year 2020 Results; Announces CEO Transition   Business Wire
Jan 11, 2021
08:10AM EST  KORU Medical Systems to Present at H.C. Wainwright BioConnect 2021 Conference   Business Wire
Nov 16, 2020
05:04PM EST  KORU Medical Reports $10M Buyback   Benzinga
05:03PM EST  KORU Medical Systems Announces Stock Repurchase Program   Business Wire
Nov 11, 2020
07:38AM EST  The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap   Benzinga
Nov 10, 2020
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 5, 2020
12:16PM EST  Canaccord Genuity Maintains Buy on Repro-Med Systems, Lowers Price Target to $10   Benzinga
Nov 4, 2020
02:43PM EST  Mid-Afternoon Market Update: Dow Jumps 600 Points; Super Micro Computer Shares Climb On Upbeat Earnings   Benzinga
10:44AM EST  Shares of small-cap company Repro Med Systems, Inc. (KRMD) slipped nearly 30% on Wednesday morning after reporting its quarter results.   RTTNews
10:24AM EST  Mid-Morning Market Update: Markets Open Higher; Performance Food Earnings Top Views   Benzinga
Nov 3, 2020
06:17PM EST  KORU Medical Systems Announces Financial Results for Third Quarter 2020   Business Wire
04:07AM EST  Earnings Scheduled For November 3, 2020   Benzinga
Oct 27, 2020
09:15AM EDT  KORU Medical Systems Schedules Release of Third Quarter 2020 Financial Results and Conference Call   Business Wire
Sep 8, 2020
11:46AM EDT  Insider Buys Repro-Med Systems Shares   Benzinga
Sep 4, 2020
11:35AM EDT  Insider Buys Repro-Med Systems Stock   Benzinga
Aug 10, 2020
04:15PM EDT  KORU Medical Systems to Present at Canaccord Genuity 40th Annual Growth Conference   Business Wire
Aug 4, 2020
05:35PM EDT  Repro-Med Systems dba KORU Medical Q2 EPS $(0.03) Misses $0.02 Estimate, Sales $7.70M Beat $6.52M Estimate   Benzinga
05:35PM EDT  Repro-Med Systems Q2 EPS $(0.03) Misses $0.02 Estimate, Sales $7.70M Beat $6.52M Estimate   Benzinga
05:34PM EDT  KORU Medical Systems Announces 2020 Second Quarter Financial Results   Business Wire
05:19AM EDT  Earnings Scheduled For August 4, 2020   Benzinga
Jul 27, 2020
09:20AM EDT  KORU Medical Systems Schedules Release of Second Quarter 2020 Financial Results and Conference Call   Business Wire
Jul 16, 2020
09:33AM EDT  Benzinga's Top Upgrades, Downgrades For July 16, 2020   Benzinga
07:13AM EDT  Canaccord Genuity Initiates Coverage On Repro-Med Systems with Buy Rating, Announces Price Target of $13   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC